Skip to content

Varilly Sciences

Active
Private limited companyfounded 201610 yrs activeWappersstraat 20, 1000 Brussel, BelgiumKBO/BCE: BE 0647.945.152
Summary

Varilly Sciences has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,460 and a net result of €55,862. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 23% of 20854 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

History

Varilly Sciences was incorporated on 9 February 2016.1 Total assets rose from €73,410 in 2018 to €83,514 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
12-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 12 days late
2025
18-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 18 days late
2024
31-12
Financial Highest result since 2018net €74,663 ▲11.8%
Operating result €96,714, net result €74,663, both a record.
17-05
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
27-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
23-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
2018
21-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 21 days late
2017
24-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 24 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.